A study to evaluate the effect of zigakibart in adults with IgA nephropathy
- Substances:ZIGAKIBART
Czechia- Participants:18–64 years · 65+ years
- Substances:ZIGAKIBART
Rare diseases
Investigational molecules
Locations
CzechiaA study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma
AustriaUsing glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes
DenmarkA study of emavusertib and zanubrutinib in patients with chronic lymphocytic leukemia and other B-cell cancers.
ItalyA study of irinotecan and a drug combination for patients with gastric cancer or gastroesophageal junction cancer undergoing surgery.
The NetherlandsA study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.
ItalyA study to evaluate the effect of rimegepant in patients with migraine and obesity
AustriaA study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain
HungaryA study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack
DenmarkA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
BulgariaStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
AustriaA study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.